OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond Cannabis: Plants and the Endocannabinoid System
Ethan B. Russo
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 7, pp. 594-605
Closed Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Phytocannabinoids: a unified critical inventory
L Hanŭs, Stefan Meyer, Eduardo Muñóz, et al.
Natural Product Reports (2016) Vol. 33, Iss. 12, pp. 1357-1392
Open Access | Times Cited: 734

Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads
Ethan B. Russo, Jahan P. Marcu
Advances in pharmacology (2017), pp. 67-134
Closed Access | Times Cited: 313

The endocannabinoid system as a target for novel anxiolytic drugs
Sachin Patel, Mathew N. Hill, Joseph F. Cheer, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 76, pp. 56-66
Open Access | Times Cited: 221

Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Sandra Blasco-Benito, Marta Seijo-Vila, Miriam Caro-Villalobos, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 285-293
Closed Access | Times Cited: 163

The Pharmacological Case for Cannabigerol
Rahul Nachnani, Wesley M. Raup‐Konsavage, Kent E. Vrana
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 376, Iss. 2, pp. 204-212
Open Access | Times Cited: 149

A new Cannabis genome assembly associates elevated cannabidiol (CBD) with hemp introgressed into marijuana
Christopher J. Grassa, George D. Weiblen, Jonathan P. Wenger, et al.
New Phytologist (2021) Vol. 230, Iss. 4, pp. 1665-1679
Open Access | Times Cited: 129

Large-scale whole-genome resequencing unravels the domestication history of Cannabis sativa
Guangpeng Ren, Xu Zhang, Ying Li, et al.
Science Advances (2021) Vol. 7, Iss. 29
Open Access | Times Cited: 124

Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh, Zoltán Szekanecz, Tamás Bı́ró
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118

Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
Ethan B. Russo
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 116

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution
Samuel D. Banister, Mark Connor
Handbook of experimental pharmacology (2018), pp. 191-226
Closed Access | Times Cited: 114

Valorizing industrial hemp (Cannabis sativa L.) by-products: Cannabidiol enrichment in the inflorescence essential oil optimizing sample pre-treatment prior to distillation
Dennis Fiorini, Arnaud Molle, Massimo Nabissi, et al.
Industrial Crops and Products (2018) Vol. 128, pp. 581-589
Closed Access | Times Cited: 111

Cannabis Therapeutics and the Future of Neurology
Ethan B. Russo
Frontiers in Integrative Neuroscience (2018) Vol. 12
Open Access | Times Cited: 110

A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 102

The Endocannabinoid System of Animals
Robert Silver
Animals (2019) Vol. 9, Iss. 9, pp. 686-686
Open Access | Times Cited: 101

Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal
Chandni Hindocha, Tom P. Freeman, Meryem Grabski, et al.
Addiction (2018) Vol. 113, Iss. 9, pp. 1696-1705
Open Access | Times Cited: 98

Cannabimimetic plants: are they new cannabinoidergic modulators?
Amit Kumar, Marika Premoli, Francesca Aria, et al.
Planta (2019) Vol. 249, Iss. 6, pp. 1681-1694
Closed Access | Times Cited: 88

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins
Samuel D. Banister, Mark Connor
Handbook of experimental pharmacology (2018), pp. 165-190
Closed Access | Times Cited: 87

Cannabidiol-enriched hemp essential oil obtained by an optimized microwave-assisted extraction using a central composite design
Dennis Fiorini, Serena Scortichini, Giulia Bonacucina, et al.
Industrial Crops and Products (2020) Vol. 154, pp. 112688-112688
Closed Access | Times Cited: 79

The short-term and long-term effects of cannabis on cognition: recent advances in the field
Emese Kroon, Lauren Kuhns, Janna Cousijn
Current Opinion in Psychology (2020) Vol. 38, pp. 49-55
Open Access | Times Cited: 73

Cannabis sativa research trends, challenges, and new-age perspectives
Tajammul Hussain, Ganga Jeena, Thanet Pitakbut, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103391-103391
Open Access | Times Cited: 57

A completeCannabischromosome assembly and adaptive admixture for elevated cannabidiol (CBD) content
Christopher J. Grassa, Jonathan P. Wenger, Clemon J. Dabney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 75

β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors
Natasha Irrera, Angela D’Ascola, Giovanni Pallio, et al.
Biomolecules (2019) Vol. 9, Iss. 8, pp. 326-326
Open Access | Times Cited: 63

Synthetic Biology of Cannabinoids and Cannabinoid Glucosides in Nicotiana benthamiana and Saccharomyces cerevisiae
Thies Gülck, Judith K. Booth, Ângela Carvalho, et al.
Journal of Natural Products (2020) Vol. 83, Iss. 10, pp. 2877-2893
Closed Access | Times Cited: 58

Page 1 - Next Page

Scroll to top